What is NovoCure's EV / sales?

NovoCure (NVCR) reported EV / sales of 1.8× in Q1 2026.

How has NovoCure's EV / sales changed year-over-year?

NovoCure's EV / sales decreased by 41.3% year-over-year, from 3× to 1.8×.

What is the long-term trend for NovoCure's EV / sales?

Over 5 years (2020 to 2025), NovoCure's EV / sales has grown at a -43.3% compound annual growth rate (CAGR), from 36.8× to 2.1×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

NovoCure NVCR EV / sales

EV / sales at other companies

Boston ScientificBSX

7×-1.5×

MedtronicMDT

3.6×-0.4×

Iovance Biotherapeutics, Inc.IOVA

4.5×0.0×

Nuvation BioNUVB

9.9×-41.1×

Vir Biotechnology, Inc.VIR

19×-10.6×

Syndax PharmaceuticalsSNDX

10.5×-17.9×

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Calculated from NovoCure’s reported figures.

enterprise value/total revenue=1.8×

Based on the most recent quarter.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's EV / sales?: NovoCure (NVCR) reported EV / sales of 1.8× in Q1 2026.
How has NovoCure's EV / sales changed year-over-year?: NovoCure's EV / sales decreased by 41.3% year-over-year, from 3× to 1.8×.
What is the long-term trend for NovoCure's EV / sales?: Over 5 years (2020 to 2025), NovoCure's EV / sales has grown at a -43.3% compound annual growth rate (CAGR), from 36.8× to 2.1×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.